Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 8, 2020
Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care
Klara M Posfay-Barbe, Diego O Andrey, Julien Virzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2024
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5
Javier Cortés, Sara A Hurvitz, Joyce O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2023
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Sara M Tolaney, Arlene Chan, Katarina Petrakova, et al.
Nature Communications
|
July 15, 2022
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer
Aditya Bardia, Sarat Chandarlapaty, Hannah M Linden, et al.
Journal of Clinical Medicine
|
July 30, 2020
Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests
Diego O Andrey, Patrick Cohen, Benjamin Meyer, et al.
European Journal of Clinical Investigation
|
July 22, 2020
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test
Diego O Andrey, Patrick Cohen, Benjamin Meyer, et al.
Molecular Imaging
|
October 26, 2020
Two Patient Studies of a Companion Diagnostic Immuno-Positron Emission Tomography (PET) Tracer for Measuring Human CA6 Expression in Cancer for Antibody Drug Conjugate (ADC) Therapy
Arutselvan Natarajan, Shyam M Srinivas, Carmen Azevedo, et al.
The Lancet. Oncology
|
April 13, 2015
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
Jean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, et al.
NPJ Precision Oncology
|
May 15, 2026
Multicentric data challenge for artificial intelligence-based classification of leukocytes: results from the CytologIA consortium
Elise Sourdeau, Franck Geneviève, Lucile Baseggio, et al.
American Journal of Human Genetics
|
July 5, 2003
A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set
Tara C Matise, Ravi Sachidanandam, Andrew G Clark, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 8, 2020
Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care
Klara M Posfay-Barbe, Diego O Andrey, Julien Virzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2024
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5
Javier Cortés, Sara A Hurvitz, Joyce O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2023
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Sara M Tolaney, Arlene Chan, Katarina Petrakova, et al.
Nature Communications
|
July 15, 2022
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer
Aditya Bardia, Sarat Chandarlapaty, Hannah M Linden, et al.
Journal of Clinical Medicine
|
July 30, 2020
Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests
Diego O Andrey, Patrick Cohen, Benjamin Meyer, et al.
European Journal of Clinical Investigation
|
July 22, 2020
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test
Diego O Andrey, Patrick Cohen, Benjamin Meyer, et al.
Molecular Imaging
|
October 26, 2020
Two Patient Studies of a Companion Diagnostic Immuno-Positron Emission Tomography (PET) Tracer for Measuring Human CA6 Expression in Cancer for Antibody Drug Conjugate (ADC) Therapy
Arutselvan Natarajan, Shyam M Srinivas, Carmen Azevedo, et al.
The Lancet. Oncology
|
April 13, 2015
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
Jean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, et al.
NPJ Precision Oncology
|
May 15, 2026
Multicentric data challenge for artificial intelligence-based classification of leukocytes: results from the CytologIA consortium
Elise Sourdeau, Franck Geneviève, Lucile Baseggio, et al.
American Journal of Human Genetics
|
July 5, 2003
A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set
Tara C Matise, Ravi Sachidanandam, Andrew G Clark, et al.
Page
of 2